N

Nanjing Vazyme Biotech Co Ltd
SSE:688105

Watchlist Manager
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Watchlist
Price: 20.02 CNY -0.35% Market Closed
Market Cap: 8B CNY

Wall Street
Price Targets

Price Targets Summary
Nanjing Vazyme Biotech Co Ltd

Wall Street analysts forecast Nanjing Vazyme Biotech Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Nanjing Vazyme Biotech Co Ltd is 28.76 CNY with a low forecast of 27.27 CNY and a high forecast of 30.86 CNY.

Lowest
Price Target
27.27 CNY
36% Upside
Average
Price Target
28.76 CNY
44% Upside
Highest
Price Target
30.86 CNY
54% Upside
Nanjing Vazyme Biotech Co Ltd Competitors:
Price Targets
CRSP
CRISPR Therapeutics AG
49% Upside
TVTX
Travere Therapeutics Inc
7% Upside
SPRB
Spruce Biosciences Inc
136% Upside
LGND
Ligand Pharmaceuticals Inc
31% Upside
ONCO
Oncopeptides AB
8% Upside
ORGO
Organogenesis Holdings Inc
87% Upside
688235
Beigene Ltd
38% Upside
MGX
Metagenomi Inc
470% Upside

Revenue
Forecast

Revenue Estimate
Nanjing Vazyme Biotech Co Ltd

For the last 5 years the compound annual growth rate for Nanjing Vazyme Biotech Co Ltd's revenue is 39%. The projected CAGR for the next 3 years is 15%.

39%
Past Growth
15%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Nanjing Vazyme Biotech Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Nanjing Vazyme Biotech Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Nanjing Vazyme Biotech Co Ltd's stock price target?
Price Target
28.76 CNY

According to Wall Street analysts, the average 1-year price target for Nanjing Vazyme Biotech Co Ltd is 28.76 CNY with a low forecast of 27.27 CNY and a high forecast of 30.86 CNY.

What is Nanjing Vazyme Biotech Co Ltd's Revenue forecast?
Projected CAGR
15%

For the last 5 years the compound annual growth rate for Nanjing Vazyme Biotech Co Ltd's revenue is 39%. The projected CAGR for the next 3 years is 15%.

Back to Top